Stocks and Investing Stocks and Investing
Tue, March 7, 2023

Anupam Rama Maintained (SWTX) at Buy with Increased Target to $57 on, Mar 7th, 2023


Published on 2024-10-28 02:08:48 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Buy with Increased Target from $53 to $57 on, Mar 7th, 2023.

Anupam has made no other calls on SWTX in the last 4 months.



There are 2 other peers that have a rating on SWTX. Out of the 2 peers that are also analyzing SWTX, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Anupam


  • Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $45 on, Thursday, January 26th, 2023
  • Alec Stranahan of "B of A Securities" Initiated at Strong Buy and Held Target at $45 on, Thursday, December 1st, 2022
Contributing Sources